LeMaitre Vascular, Inc. LMAT

81.52 0.70 0.87% as of 25 Sep
Market cap
$1.9B
P/E
28.1×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
89.15 100.87 105.57 117.23 129.37 154.42 161.65 193.48 219.86 249.60
Revenue Growth
13.78% 13.14% 4.66% 11.05% 10.35% 19.37% 4.68% 19.69% 13.63% 13.53%
Cost of Revenue
26.22 30.17 31.63 37.38 44.75 53.04 56.76 66.44 68.96 71.06
Gross Profit
62.94 70.70 73.94 79.85 84.62 101.38 104.90 127.05 150.90 178.54
R&D Expenses
6.14 6.64 8.20 9.28 10.10 11.80 13.29 16.97 15.65 14.14
SG&A Expenses
40.46 42.96 45.01 49.39 46.20 53.16 61.67 72.89 83.00 96.49
Operating Income
16.34 21.10 28.21 21.18 28.79 36.43 26.83 36.71 52.26 67.91
Non-operating Income/Expense
(0.09) 0.00 0.24 0.50 (1.43) (2.14) 0.66 2.76 4.62 7.27
Non-operating Interest Expenses
0.01 0.02 0.00 0.00 1.31 2.22 0.00 0.00 0.21 5.18
EBT
16.24 21.11 28.44 21.68 27.36 34.29 27.49 39.48 56.88 75.18
Income Tax Provision
5.65 3.93 5.50 3.75 6.14 7.38 6.85 9.37 12.84 17.45
Income after Tax
10.59 17.18 22.94 17.93 21.22 26.91 20.64 30.11 44.04 57.73
Dividends (Preferred)
— 0.00 — 0.00 0.00 0.00 — — 0.00 0.00
Net Income Common
10.59 17.18 22.94 17.93 21.22 26.91 20.64 30.11 44.04 57.73
EPS (Basic)
0.57 0.91 1.18 0.91 1.05 1.27 0.94 1.36 1.96 2.55
EPS (Diluted)
0.55 0.86 1.13 0.88 1.04 1.25 0.93 1.34 1.93 2.52
Shares (Basic, Weighted)
18.49 18.96 19.43 19.81 20.25 21.16 21.98 22.22 22.45 22.64
Shares (Diluted, Weighted)
19.24 20.03 20.24 20.33 20.48 21.48 22.17 22.42 22.78 22.93
Gross Margin
70.59% 70.09% 70.04% 68.12% 65.41% 65.65% 64.89% 65.66% 68.63% 71.53%
EBIT Margin
18.32% 20.92% 26.72% 18.07% 22.25% 23.59% 16.60% 18.97% 23.77% 27.21%
EBT margin
18.22% 20.92% 26.94% 18.49% 21.15% 22.20% 17.01% 20.40% 25.87% 30.12%
Net Profit Margin
11.88% 17.03% 21.73% 15.30% 16.40% 17.42% 12.77% 15.56% 20.03% 23.13%
Free Cash Flow Margin
15.76% 16.31% 15.58% 8.89% 26.16% 19.57% 14.23% 15.24% 16.90% 29.83%
EBITDA
19.93 25.16 32.53 26.60 37.18 47.50 36.26 46.23 61.93 79.20
EBIT
16.34 21.10 28.21 21.18 28.79 36.43 26.83 36.71 52.26 67.91
Income from Continuous Operations
10.59 17.18 22.94 17.93 21.22 26.91 20.64 30.11 44.04 57.73
Consolidated Net Income/Loss
10.59 17.18 22.94 17.93 21.22 26.91 20.64 30.11 44.04 57.73
EPS (Basic, from Continuous Ops)
0.57 0.91 1.18 0.91 1.05 1.27 0.94 1.36 1.96 2.55
EPS (Basic, Consolidated)
0.57 0.91 1.18 0.91 1.05 1.27 0.94 1.36 1.96 2.55
EPS (Diluted, from Cont. Ops)
0.55 0.86 1.13 0.88 1.04 1.25 0.93 1.34 1.93 2.52
Shares (Diluted, Average)
19.24 20.03 20.24 20.33 20.48 21.48 22.17 22.42 22.78 22.93
EPS (Diluted, Consolidated)
0.55 0.86 1.13 0.88 1.04 1.25 0.93 1.34 1.93 2.52
EBITDA Margin
22.35% 24.94% 30.82% 22.69% 28.74% 30.76% 22.43% 23.89% 28.17% 31.73%
Operating Cash Flow Margin
18.95% 22.67% 18.48% 12.09% 26.90% 22.73% 15.70% 18.99% 20.07% 32.55%

Fold the line items

In millions of $ except per-share values · columns are period end dates